Comment on CMS-2026-1256-0002

Summary: Stryker, a medical technology company, generally supports the proposed FY 2027 Medicare IPPS policy changes, including new technology add-on payments and mandatory eCQMs. However, the company opposes specific MS-DRG reconfigurations for hip and knee revisions, arguing they would lead to underpayment and clinical confusion, and requests the retention of alternative pathways for Breakthrough Devices.